CSG's €42 Billion Order Backlog Can't Mask the Pain of a 53% Share Price Wipeout

Czechoslovak Group trades near 52-week low amid regulatory, EU funding, and earnings catalysts that could determine its next move.

A defence contractor with a €42 billion order book, a double-digit revenue surge, and unanimous buy ratings from analysts shouldn't be trading at half its January peak. Yet that is exactly where the Czechoslovak Group (CSG) finds itself, with shares closing at €15.98 — barely above their 52-week low. The disconnect between market sentiment and fundamental outlook has rarely been starker.

The numbers tell a brutal story. From a January high of €33.81, the stock has shed roughly 53% of its value. The past 30 days alone have seen a decline of more than a third, leaving investors nursing heavy losses. Annualised volatility now exceeds 84%, a level that would test the nerve of even the most seasoned portfolio manager.

Three Catalysts Converge in a Single Window

CSG is staring down a compressed calendar of events that could determine whether the stock has found a floor — or has further to fall. By the end of May, the company expects clarity on three fronts: a regulatory decision on a key acquisition, a European Union financing deadline, and its first quarterly earnings report since going public.

The acquisition in question is a 49% stake in Hirtenberger Defence Systems (HDS), an Austrian specialist in mortar ammunition. The deal, struck with Hungarian conglomerate 4iG, would bolster CSG's ammunition and land systems portfolio and mark its first operational footprint in Austria. Both sides are also exploring the creation of a joint venture in Slovakia. Regulatory approval remains pending.

Running in parallel is a ticking clock on EU funding. The bloc's SAFE programme offers member states loans at 1% interest with maturities of up to 40 years for defence projects. Slovakia can only access these terms if at least one other EU country joins the arrangement — and that exception expires at the end of May. If Bratislava fails to secure a partner by then, cheap financing for future ammunition purchases becomes far more difficult. CSG has been careful to note that its €58 billion framework agreement with the Slovak government represents a maximum potential, not firm orders, and that the company is not reliant on any single funding mechanism.

The Earnings Report That Matters More Than Most

On 20 May, CSG will publish its first quarterly results as a listed company. The report will include IPO-related costs incurred after the year-end, giving investors their first real chance to assess whether margins can hold up under one-off charges.

Management has stuck to its full-year guidance: revenue between €7.4 billion and €7.6 billion, with an operating EBIT margin of 24% to 25%. The medium-term target is 26% to 28%. For context, the company grew revenue by nearly 72% in fiscal 2025 to €6.7 billion, and its order backlog stands at roughly €42 billion — equivalent to several years of revenue visibility.

The earnings call will also give the board an opportunity to address a short-seller report from Hunterbrook Media, which CSG has dismissed as containing inaccurate representations of its business model and governance. The allegations have not been independently verified, but they have clearly weighed on the stock.

Analysts See Value Where Markets See Risk

The divergence between analyst opinion and market pricing is striking. All nine analysts covering CSG rate the stock a buy, with a median price target of €35.40 — more than double the current share price. Moody's recently upgraded the company to investment grade (Baa3), citing improved corporate governance.

Yet the market remains unconvinced. The short-seller overhang, combined with uncertainty around the Slovak financing framework and the Hirtenberger approval, has created a cloud that only hard data can disperse.

Operationally, the business continues to fire on all cylinders. CSG recently signed a cooperation agreement with Polish defence group PGZ, and a Western European customer placed an order for 155mm artillery ammunition worth nearly €250 million.

Whether the stock has bottomed out should become clear by the end of May. The Hirtenberger decision, the SAFE deadline, and the quarterly report all fall within a tight window — and each carries enough weight to move the shares in either direction. For investors, the next few weeks will be anything but quiet.